August 18, 2016
Nearly all 50 states have lured Hollywood productions with millions of dollars in special tax incentives for filmmaking, but new USC research shows they fail to deliver the long-term economic benefits promised by industry lobbyists and lawmakers. “The incentives are a bad investment. States pour millions of tax dollars into a program that offers little return,” said lead author Michael Thom, an assistant professor at the USC Price School of Public Policy.
July 20, 2016
In recognition of his outstanding scholarly contributions, USC Price School of Public Policy Professor Robert Denhardt has received academic excellence awards from the American Society for Public Administration’s Los Angeles and Sacramento chapters this summer. Denhardt was honored with the Chester Newland Award from the Sacramento chapter in early June, and then the Harry Scoville Award from the Los Angeles chapter in July.
July 5, 2016
A new study shows a large number — nearly 15 percent — of Medicare patients receive their first prescription for opioids within a week of being discharged from the hospital. The study published on June 13 by JAMA Internal Medicine is one of the first to quantify the rate of new opioid prescription amid growing national concern about the use of addictive painkillers. Dana Goldman, USC Price School of Public Policy professor and director of the Schaeffer Center for Health Policy and Economics, co-authored the study.
July 1, 2016
Downplaying headlines announcing that the federal hospital trust fund will be insolvent by 2028, Medicare Actuary Paul Spitalnic instead stressed other projections in the 2016 Medicare Trustees report that warn of longer term dangers. The newly released 261-page report is the latest annual review of the state of Medicare finances submitted to Congress and the public. Spitalnic spoke at a panel in Washington D.C. sponsored by the American Enterprise Institute and the Schaeffer Initiative for Innovation in Health Policy, a partnership between the USC Schaeffer Center for Health Policy & Economics and the Brookings Institution.
Rose research team finds pandemic influenza may have much higher negative economic impacts than prior studies
June 28, 2016
An influenza pandemic would cost the nation tens of billions of dollars in economic losses – nearly double what previous estimates showed, a new study shows. Published on June 28 in Risk Analysis: An International Journal, the USC-led study found that the nation would lose as much as $45 billion in gross domestic product if Americans failed to get vaccinated for the flu, versus $34 billion if they were vaccinated. USC Price’s Adam Rose was the study’s team leader.